期刊文献+

转染VMAT_2基因的中国仓鼠卵巢细胞对毒物抵抗作用的研究 被引量:1

Resistance of the Transgenic CHO Cell to Toxicity
下载PDF
导出
摘要 目的:研究毒物鱼藤酮和1-甲基-4-苯基吡啶离子(MPP+)对野生型及转染囊泡单胺转运蛋白(VMAT2)基因的中国仓鼠卵巢细胞(CHO)的毒性作用。方法:将不同浓度的MPP+、鱼藤酮与野生型CHO细胞(WT-CHO)和转染VMAT2基因的CHO细胞(VMAT2-CHO)共同培养,采用细胞MTT比色法和形态学观察,探讨毒物对细胞的毒性作用,通过激光共聚焦显微镜观察毒物对2种细胞的细胞内钙浓度([Ca2+]i)的影响。结果:VMAT2-CHO在一定时间(72 h)内对MPP+(0.2-2.0 mmol/L)和鱼藤酮(0.05-1.0μmol/L)的毒性有抵抗作用(P<0.05)。结论:VMAT2可以抵抗一定浓度的MPP+和鱼藤酮引起的神经细胞毒性作用。 Objective: The toxicity to transgenic CHO of vesicular monoamine transporter 2 (VMAT2) and to wild type CHO generated by MPP^+ and Rotenone was assessed, Methods: MTT assay was used to detect cell survival rate of both WTCHO and VMAT2-CHO following exposure to MPP^+ and Rotenone, Meanwhile the change of cell morphology was observed, Fluorescence intensity of intracellular Ca^2+ concentration in the two groups of cells was measured under the Confocal laser microscopy, Results:Transgenic VMAT2-CHO cells were resistent to the toxicity of MPP^+ ( the concentration range: 0.2 2.0 mmol/L) and Rotenone( the concentration range: 0.05-1. 0μmol/L). Conclusion: Transgenic CHO cells with VMAT2 can resist the toxicity caused by Rotenone and MPP^+ .
出处 《神经损伤与功能重建》 2006年第1期31-34,共4页 Neural Injury and Functional Reconstruction
基金 河北省自然科学基金资助项目(303497)
关键词 囊泡单胺转运蛋白 CHO 细胞毒性 细胞内钙浓度 毒物抵抗作用 VMAT2 CHO cell toxicity intracellular Ca^2+
  • 相关文献

参考文献14

  • 1JENNER P,OLANOW CW. Oxidative Stress and the Pathogenesis of Parkinson' s Disease [J]. Neurology (S0028-3878),1996, 47(6 suppl 3):161-170.
  • 2张卫国,史雪勤,王小虎,谢国建,李胜保,吴清明.不同浓度DMSO对胃癌细胞生长的影响[J].重庆医学,2004,33(11):1731-1732. 被引量:13
  • 3TRUONG JG, HANSON GR, FLECKENSTEIN AE.Apomorphine Increases Vesicular Monoamine Transporter 2 Function: Implications for Neurodegeneration [J]. Eur J Pharmacol(S0014 - 2999), 2004, 492 (2-3): 143-147.
  • 4HAIKERWAL D, DART AM, LITTLE PJ, et al. Identification of a Novel Inhibitory Action of Amiodarone on Vesicular Monoamine Transport[J]. J Pharmacol Exp Ther(S0022-3565),1999, 288(2):834-837.
  • 5BLACKMORE CG,VARRO A, DIMALINE R,et al.Measurement of Secretory Vesicle pH Reveals Intravesicular Alkalinization by Vesicular Monoamine Transporter Type-2 Resulting in Inhibition of Prohormone Cleavage[J]. Journal of Physiology (S0022 - 3565),2001,531(3) :605-617.
  • 6ERICKSON JD,EIDEN LE, HOFFMAN BJ. Expression Cloning of a Reserpine-sensitive Vesicular Monoamine Transporter [J]. Proc Natl Acad Sci USA (S1009-3079),1992,89(22):10993-10997.
  • 7ROLAND GW, PATRICIA K. Sonsalla Inhibition of Brain Vesicular Monoamine Transporter (VMAT2)Enhances 1-Methyl-4-phenylpyridinium Neurotoxicity in Vivo in Rat Striata[J]. JPET (S0022-3565),2000, 293(2) :336-342.
  • 8TAKAHASHI N, MINER LL, SORA I, et al.VMAT2 Knockout Mice: Heterozygotes Display Reduced Amphetamine-conditioned Reward, Enhanced Amphetamine Locomotion, and Enhanced MPTP Toxicity[J]. Proc Natl Acad Sci USA(S1009-3079),1997, 94(18):9938-9943.
  • 9高利平,方海立.钙超载与细胞损伤[J].四川医学,2004,25(9):1039-1041. 被引量:14
  • 10叶民,丁新生,董海蓉,仇镇宁,管晓虹.转基因CHO细胞中VMAT_2抗毒性作用的研究[J].临床神经病学杂志,2002,15(2):69-72. 被引量:7

二级参考文献21

  • 1[1]Timothy Denton,Bruce DH.A dopaminergic cell line variant resistant to the neurotoxin 1-Methyl-4-phenyl-1,2,3,6-Tetrahydropyridine.J Neurochem,1987,49:622
  • 2[2]Yongjian Liu,Doris Peter,Ali Roghani,et al.A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter.Cell,1992,21:539
  • 3[3]Yongjian Liu,Robert HE.The role of vesicular transport proteins in synaptic transmission and neural degeneration.Annu Rev Neurosci,1997,20:125
  • 4[4]Uhl GR.Hypothesis: The role of dopaminergic transporters in selective vulnerability of cells in parkinson's disease.Ann Rev Neurology,1998,43:555
  • 5[5]Trimbele WS,Linial M,Scheller RH.Celluar and molecular biology of the presynaptic nerve terminal.Annu Rev Neurosci,1991,14:93
  • 6[6]Hirsch EC.Mechanism and consequences of nerve cell death in Parkinson's disease.J Neural Transm Suppl,1999,56:127
  • 7[7]Masserana JM,Gong L,Kulaga H,et al.Dopamine induced apoptotic cell death of a catecholaminergic cell line derived from the central nervous system.Mol Parmacol,1996,50:1309
  • 8[8]Hurd Y,Pristupa Z,Herman M,et al.The dopamine transporter and dopamine D2 receptor mRNAs are differentially expressed in limbic-and motor-related subpopulation of human mesencephalic neurons.Neuroscience,1994,63:357
  • 9[9]Uhl GR,Walther D,Mash D,et al.Dopamine transporter messenger RNA in Parkinson's disease and control substantia nigra neurons.Ann Neurol,1994,35:494
  • 10[10]Takahashi N,Uhl GR.Mouse synaptic vesicular monoamine transporter molecular cloning and genomic structure.Mol Rain Res,1997,49:7

共引文献31

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部